Alarmins MRP8 and MRP14 induce stress tolerance in phagocytes under sterile inflammatory conditions

Judith Austermann1, Judith Friesenhagen2, Selina Kathleen Fassl3

  • 1Institute of Immunology, University of Münster, 48149 Münster, Germany; Interdisciplinary Centre for Clinical Research, University of Münster, 48149 Münster, Germany.

Cell Reports
|December 16, 2014
PubMed

Insights

Endogenous alarmins, myeloid-related proteins (MRPs), induce phagocyte hyporesponsiveness through chromatin changes, enhancing survival in septic shock models. This alarmin-triggered tolerance impacts neonatal susceptibility to infections and inflammation.

Area of Science:

  • Immunology
  • Molecular Biology
  • Pathophysiology

Background:

  • Phagocyte hyporesponsiveness is a known issue in sepsis, often triggered by Toll-like receptor 4 (TLR4) activation.
  • This phenomenon also occurs during sterile inflammatory conditions.

Purpose of the Study:

  • To investigate the role of endogenous alarmins, specifically myeloid-related proteins (MRPs) MRP8 and MRP14, in inducing phagocyte hyporesponsiveness.
  • To determine if this alarmin-induced hyporesponsiveness affects survival in a septic shock model.

Main Methods:

  • Demonstrated alarmin-induced hyporesponsiveness via TLR4-dependent chromatin modifications.
  • Assessed survival rates in mice subjected to septic shock.
  • Measured serum MRP concentrations in trauma patients and in murine models of neonatal endotoxemia.

Main Results:

  • Endogenous alarmins MRP8 and MRP14 induce phagocyte hyporesponsiveness through TLR4-dependent chromatin modifications.
  • This hyporesponsiveness led to enhanced survival in mice challenged with septic shock.
  • High serum MRP concentrations were observed in trauma patients and in neonatal endotoxemia models.

Conclusions:

  • Alarmin-triggered phagocyte tolerance is a regulatory mechanism.
  • This mechanism influences the susceptibility of neonates to systemic infections and sterile inflammation.
  • MRPs play a critical role in modulating immune responses during inflammation and infection.